Skip to Content
Angela Gibson, MD, PhD

Surgical Services

Contact Angela


(608) 265-9574

600 Highland Ave.
MC 3236
Madison, WI 53792

(608) 262-9746

Angela Gibson, MD, PhD

Assistant Professor
Division of Trauma, Acute Care Surgery, Burn and Surgical Critical Care
Divisions of General Surgery


  • MD, University of Wisconsin School of Medicine and Public Health, 2009
  • PhD, Cellular and Molecular Biology, University of Wisconsin, 2007
  • General Surgery Residency, University of Wisconsin Hospital and Clinics, Madison, WI, 2014
  • Burn Surgery Fellowship, University of California-Davis, Sacramento, CA, 2015
  • Surgical Critical Care Fellowship, University of Wisconsin Hospital and Clinics, Madison, WI, 2015

Clinical Specialties

Dr. Gibson is certified by the American Board of Surgery in General Surgery and Surgical Critical Care. She specializes in the surgical treatment of trauma and burns, and surgical critical care.

Dr. Gibson provides a wide range of services including Burn Surgery, Management of Complicated Wounds, and Trauma Surgery.

Research Interests

Dr. Gibson’s research interests focus on epithelial regeneration in burn injury, development and testing of skin substitutes, understanding the contribution of mesenchymal stem cells in burn wound healing, and identifying the role of the host defense peptides in burn wound healing.

Active Clinical Trials

Recent Publications
  • Readmission after delayed diagnosis of surgical site infection: a focus on prevention using the American College of Surgeons National Surgical Quality Improvement Program.
    Gibson A, Tevis S, Kennedy G
    Am. J. Surg. 2014 Jun; 207(6):832-9.
    [PubMed ID: 24119885, PMC ID: 4811594]
    More Information
  • Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds.
    Gibson AL, Thomas-Virnig CL, Centanni JM, Schlosser SJ, Johnston CE, Van Winkle KF, Szilagyi A, He LK, Shankar R, Allen-Hoffmann BL
    Wound Repair Regen 2012 May-Jun; 20(3):414-24.
    [PubMed ID: 22564233, PMC ID: 3349450]
    More Information
  • Molten copper inhalation.
    Gibson A, Faucher L, Schurr M
    Burns 2011 Sep; 37(6):e50-3.
    [PubMed ID: 21726951]
    More Information
  • Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.
    Rasmussen CA, Gibson AL, Schlosser SJ, Schurr MJ, Allen-Hoffmann BL
    Ann. Surg. 2010 Feb; 251(2):368-76.
    [PubMed ID: 20010085, PMC ID: 3015240]
    More Information
  • Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen.
    Straseski JA, Gibson AL, Thomas-Virnig CL, Allen-Hoffmann BL
    Wound Repair Regen 2009 Jul-Aug; 17(4):606-16.
    [PubMed ID: 19614926, PMC ID: 2743024]
    More Information
  • Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.
    Schurr MJ, Foster KN, Centanni JM, Comer AR, Wicks A, Gibson AL, Thomas-Virnig CL, Schlosser SJ, Faucher LD, Lokuta MA, Allen-Hoffmann BL
    J Trauma 2009 Mar; 66(3):866-73; discussion 873-4.
    [PubMed ID: 19276766, PMC ID: 2679581]
    More Information
  • Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.
    Thomas-Virnig CL, Centanni JM, Johnston CE, He LK, Schlosser SJ, Van Winkle KF, Chen R, Gibson AL, Szilagyi A, Li L, Shankar R, Allen-Hoffmann BL
    Mol. Ther. 2009 Mar; 17(3):562-9.
    [PubMed ID: 19190595, PMC ID: 2736055]
    More Information
  • Comparison of therapeutic antibiotic treatments on tissue-engineered human skin substitutes.
    Gibson AL, Schurr MJ, Schlosser SJ, Comer AR, Allen-Hoffmann BL
    Tissue Eng Part A 2008 May; 14(5):629-38.
    [PubMed ID: 18439105]
    More Information Copyright © 2016 The Board of Regents of the University of Wisconsin System